Results 181 to 190 of about 565,751 (376)

Randomised trial on treatment of vaginal high‐grade squamous intraepithelial lesion: Self‐administered vaginal imiquimod and laser vaporisation

International Journal of Cancer, EarlyView.
What's New? Vaginal high‐grade squamous intraepithelial lesions (HSILs), precursors of vaginal cancer that are related to human papillomavirus (HPV) infection, often are treated with laser vaporization. HSIL treated in this way, however, tends to recur.
Mari Kiviharju, Annika Riska, Ilkka Kalliala, Maija Jakobsson, Annu Heinonen, Joakim Dillner, Pekka Nieminen, Karoliina Aro   +7 more
wiley   +1 more source

SARS-CoV-2 Vaccines and Adverse Effects in Gynecology and Obstetrics: The First Italian Retrospective Study. [PDF]

Int J Environ Res Public Health, 2022
Dellino M, Lamanna B, Vinciguerra M, Tafuri S, Stefanizzi P, Malvasi A, Di Vagno G, Cormio G, Loizzi V, Cazzato G, Tinelli R, Cicinelli E, Pinto V, Daniele A, Maiorano E, Resta L, De Vito D, Scacco S, Cascardi E.   +18 more
europepmc   +1 more source

The 1950 Year Book of Obstetrics and Gynecology (August, 1949-July, 1950) [PDF]

, 1951

openalex   +1 more source

Mass cytometric detection of homologous recombination proficiency in circulating tumor cells to predict chemoresistance of metastatic breast cancer patients

International Journal of Cancer, EarlyView.
What's New? Circulating tumor cells can offer insights into treatment responses and metastatic recurrence, but current analysis methods are limited. Here, the authors tested a newly developed mass cytometry panel comprising biomarkers such as γH2AX and RAD51 in longitudinally monitored metastatic breast cancer patients.
Kathrin Niedermayer, Henning Schäffler, Georgios Vlachos, Sara Greco, Kerstin Pfister, Barbara Volz, Leonie Ott, Hans Neubauer, Bernhard Polzer, André Koch, Sabine Riethdorf, Tanja Fehm, Wolfgang Janni, Thomas W. P. Friedl, Brigitte Rack, Ellen Heitzer, Fabienne Schochter, Lisa Wiesmüller   +17 more
wiley   +1 more source

Prognostic impact of p16 and high‐risk HPV DNA in ~1300 patients with vulvar cancer

International Journal of Cancer, EarlyView.
What's New? Vulvar cancer (VSCC) is rare, and little is known about early prognostic factors that could contribute to an individualized treatment plan. About 30%–40% of VSCCs are associated with human papillomavirus (HPV). Here, the authors investigated the prognostic influence of p16 status in VSCC in a large cohort of 1300 patients.
Susanne K. Kjær, Kirsten Frederiksen, Christina L. Rasmussen, Louise T. Thomsen, Else M. Madsen, Maria B. Franzmann, Alexander K. Kjær, Lise G. Larsen, Nadia V. Salinas, Doris Schledermann, Birgitte H. Winberg, Pernille T. Jensen, Dorthe Ørnskov, Marianne Waldstrøm, Louise Baandrup   +14 more
wiley   +1 more source

Assessing Endoscopic Suture Performance of Gynecology and Obstetrics Residents Following Methodic Training. [PDF]

Rev Bras Ginecol Obstet, 2023
Nogueira LR, Lustosa KA, Galindo LAO, Castro SE, Picanço LR, Silva LLD, Coutinho SS, Bezerra LRPS.   +7 more
europepmc   +1 more source

Introduction to the course of obstetrics and gynecology in connection with clinical methods of teaching

, 1898
A. A. Muratov
openalex   +2 more sources

A promising frontier of circulating messenger RNA in liquid biopsy: From mechanisms to clinical applications

International Journal of Cancer, EarlyView.
Abstract Liquid biopsy can revolutionize cancer patient management as repeated sampling allows real‐time monitoring of disease progression and response to treatment. The circulating transcriptome represents a rich source of potential cancer biomarkers, including coding and non‐coding RNAs.
Mengqian Li, Yijin Yu, Guangyue Liu, Shunhong Zhang, Chenchen Luo, Saidi Hu, Siran Wan, Linyong Zhao   +7 more
wiley   +1 more source

About the Performance of Latin American Gynecology and Obstetrics Journals in the International Scenario. [PDF]

Rev Bras Ginecol Obstet, 2022
Sá MFS.
europepmc   +1 more source

Diagnostic tasks for obstetrics and gynecology

, 1895
N. Kakushkin
openalex   +2 more sources